摘要号：97

英文标题：JAK/Rock Inhibitor Rovadicitinib for Glucocorticoid-Refractory or -Dependent Chronic Graft-Versus-Host Disease: Updated Results of Multicenter, Phase 1b/2a Trial

时间：Saturday, December 7, 2024: 9:30 AM

报告人：Yanmin Zhao

摘要号：99

英文标题：A Phase II Study to Evaluate the Efficacy and Safety of Pimicotinib (ABSK021) in Chronic Graft Versus Host Disease (cGvHD) after 1 or More Lines of Systemic Treatment

时间：Saturday, December 7, 2024: 10:00 AM

报告人：Depei Wu

摘要号：101

英文标题：Multiomic Analyses Uncover Immune Signatures of Steroid-Refractory Graft-Versus-Host Disease

时间：Saturday, December 7, 2024: 10:30 AM

报告人：Zengkai Pan

摘要号：477

英文标题：Safety and Efficacy of Tgrx-678, a Potent BCR::ABL1 allosteric Inhibitor, in Patients with Tyrosine Kinase Inhibitor Resistant and/or Intolerant Chronic Myeloid Leukemia: Updated Results of Phase 1 Study Tgrx-678 -1001

时间：Sunday, December 8, 2024: 10:00 AM

报告人：Qian Jiang

摘要号：480

英文标题：Olverembatinib As Second-Line (2L) Therapy in Patients (pts) with Chronic Phase-Chronic Myeloid Leukemia (CP-CML)

时间：Sunday, December 8, 2024: 10:45 AM

报告人：Li Weiming

摘要号：304

英文标题：Hetrombopag Added to Immunosuppressive Therapy in First-Line Treatment of Severe Aplastic Anemia: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial

时间：Saturday, December 7, 2024: 4:45 PM

报告人：Fengkui Zhang

摘要号：681

英文标题：Safety and Efficacy of Bicistronic CD19/CD22 CAR T Cell Therapy in Childhood B Cell Acute Lymphoblastic Leukemia

时间：Sunday, December 8, 2024: 5:00 PM

报告人：Hua Zhang

摘要号：682

英文标题：CD19 CAR T-Cell Therapy in Refractory Autoimmune Hemolytic Anemia

时间：Sunday, December 8, 2024: 5:15 PM

报告人：Ruonan Li

摘要号：683

英文标题：Sequential Infusion of Anti-CD19 and Anti-BCMA Chimeric Antigen Receptor T-Cells: A Promising Treatment Strategy for Refractory Immune-Mediated Platelet Transfusion Refractoriness

时间：Sunday, December 8, 2024: 5:30 PM

报告人：Yunju Ma

摘要号：378

英文标题：A Multi-Center Clinical Trial of Allogeneic Hematopoietic Stem Cell Transplants in Transfusion Dependent Thalassemia

时间：Saturday, December 7, 2024: 5:15 PM

报告人：Rongrong Liu

摘要号：711

英文标题：Preliminary Efficacy and Safety Results of TQB3473, a Novel Syk Inhibitor, in Adult Patients with Immune Thrombocytopenia (ITP)

时间：Monday, December 9, 2024: 11:00 AM

报告人：Hu Zhou

摘要号：712

英文标题：Updated Outcome from Biomarker MSC-C5b-9-Guided All-Trans Retinoic Acid Treatment for Resistant/Recurrent ITP: A Multicenter, Randomized, Open-Label, Phase 3 Clinical Trial

时间：Monday, December 9, 2024: 11:15 AM

报告人：Menglin Li

摘要号：663

英文标题：Decitabine Plus All-Trans Retinoic Acid Versus Decitabine Monotherapy for Myelodysplastic Syndromes with Excess Blasts: A Multicentre, Randomized Controlled Trial

时间：Sunday, December 8, 2024: 5:00 PM

报告人：Hongyan Tong

摘要号：1049

英文标题：Mini-Dosed Blinatumomab Maintenance Therapy Following Allogeneic Hematopoietic Stem Cell Transplantation in Acute B-Cell Lymphoblastic Leukemia

时间：Monday, December 9, 2024: 5:30 PM

报告人：Jie Ji

摘要号：1050

英文标题：Updated Results from a Phase Ⅱ Clinical Trial：Safety and Efficacy of Azacitidine and Chidamide Maintenance after Allogeneic Hematopoietic Stem Cell Transplantation for Patients with High-Risk Acute Myeloid Leukemia

时间：Monday, December 9, 2024: 5:45 PM

报告人：Rui Huang

摘要号：91

英文标题：Rituximab, Lenalidomide, and Zanubrutinib (ZR2) with Sequential CAR-T Cell As First-Line Therapy for High-Risk Large B Cell Lymphoma

时间：Saturday, December 7, 2024: 9:30 AM

报告人：Mingming Zhang

摘要号：92

英文标题：IL-10 Expressing CD19 CAR-T Cells Induce Complete Remission and Improve Long-Term Protection in Relapsed or Refractory B-Cell Hematological Malignancies

时间：Saturday, December 7, 2024: 9:45 AM

报告人：Jingjing Ren

摘要号：956

英文标题：A Highly Selective and Orally Bioavailable CK1α Molecular Glue Degrader Targets B-Cell Lymphoma Cells

时间：Monday, December 9, 2024: 4:45 PM

报告人：Ran Kong

摘要号：958

英文标题：KPT-330 Combined with Radiation Therapy: Effective Central Nervous System Lymphoma Treatment with Reduced Neurotoxicity

时间：Monday, December 9, 2024: 5:15 PM

报告人：Bingzong Li

摘要号：960

英文标题：CD93+ Myeloid Cells Suppress T-Cell-Mediated Anti-Tumor Immunity

时间：Monday, December 9, 2024: 5:45 PM

报告人：Hui Yu

摘要号：836

英文标题：Venetoclax Combined with Hag Regimen in Newly Diagnosed ETP-ALL: A Prospective, Multicenter, Phase 2 Trial

时间：Monday, December 9, 2024: 3:00 PM

报告人：Shanshan Suo

摘要号：839

英文标题：Tucidinostat Plus Pediatric-Inspired Chemotherapy As First-Line Therapy for Newly Diagnosed ETP-ALL/Lbl: An Open-Label, Single-Arm, Phase 2 Trial

时间：Monday, December 9, 2024: 3:45 PM

报告人：Jieping Lin

摘要号：986

英文标题：Final Analysis of a Phase 1 Study of Zanubrutinib Plus Lenalidomide in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

时间：Monday, December 9, 2024: 4:45 PM

报告人：Zheng Song

摘要号：806

英文标题：Rovadicitinib in Patients with Hemophagocytic Lymphohistiocytosis: A Single Arm, Open-Label, Phase I Study

时间：Monday, December 9, 2024: 3:00 PM

报告人：Zhao Wang

摘要号：810

英文标题：Pharmacological and Mechanism Study of a New RIPK1 Inhibitor Via Necroptosis to Treat Hemophagocytic Lymphohistiocytosis

时间：Monday, December 9, 2024: 4:00 PM

报告人：Jinbing Zhu

摘要号：1028

英文标题：A Single-Center, Single-Arm, Phase I Clinical Trial of Anti-BCMA/GPRC5D Bispecific CAR T-Cells in Patients with Refractory and Relapsed Multiple Myeloma with Extramedullary Disease

时间：Monday, December 9, 2024: 4:45 PM

报告人：Ling Qiu

摘要号：921

英文标题：A Novel Generation of Anti-CD7 Universal CAR-T Therapy for Patients with Relapsed or Refractory CD7 Positive T-ALL/Lbl: A Phase I Clinical Trial

时间：Monday, December 9, 2024: 3:15 PM

报告人：Yongxian Hu

摘要号：923

英文标题：A Prospective Investigator-Initiated Phase 1/2 Study of BCMA/CD19 Dual-Targeting CAR T Therapy in Patients with Relapsed/Refractory Multiple Myeloma Including Those with Extramedullary Disease

时间：Monday, December 9, 2024: 3:45 PM

报告人：Hua Jiang

摘要号：484

英文标题：Rovadicitinib in Patients with Myelofibrosis Who Were Refractory or Relapsed or Intolerant to Ruxolitinib: A Single Arm, Multicenter, Open-Label, Phase Ib Study

时间：Sunday, December 8, 2024: 10:15 AM

报告人：Chunkang Chang

摘要号：486

英文标题：First-in-Human Phase I/IIa Safety and Efficacy of Flonoltinib Maleate, a New Generation of JAK2/FLT3 Inhibitor in Myelofibrosis

时间：Sunday, December 8, 2024: 10:45 AM

报告人：Lijuan Chen

摘要号：1002

英文标题：The Efficacy and Safety of Selinexor in Combination with Ruxolitinib in Ruxolitinib-Treated Myelofibrosis Patients: The Interim Analysis of a Prospective, Open-Label, Multicenter, Parallel-Cohort, Phase 2 Study

时间：Monday, December 9, 2024: 5:45 PM

报告人：Minghui Duan

摘要号：832

英文标题：TENT5C As a Target of Chromatin Remodeler SMARCA2 Participates BTK Inhibitor Resistance in Mantle Cell Lymphoma By Regulating ATP Metabolism

时间：Monday, December 9, 2024: 3:30 PM

报告人：Yuting Yan

摘要号：833

英文标题：ST6GALNAC4 Promotes Diffuse Large B-Cell Lymphoma Progression Via Mediating Sialylation of Bmpr-1B at Thr24

时间：Monday, December 9, 2024: 3:45 PM

报告人：Yu Zhang

摘要号：89

英文标题：Targeted-Delivery Strategy of Engineered EV Functionalized By Anti-CD3/CD19 Bi-Specific T-Cell Engager in Treating B-Cell Malignancies

时间：Saturday, December 7, 2024: 10:30 AM

报告人：Xiuiu Yang

摘要号：437

英文标题：ERAD Activity Distinguishes the Functional Heterogeneity of Hematopoietic Stem Cells

时间：Sunday, December 8, 2024: 10:30 AM

报告人：QinLu Peng

摘要号：438

英文标题：SNORD113-114 Cluster Maintains Hematopoietic Stem Cell Self-Renewal Via Orchestrating the Translation Machinery

时间：Sunday, December 8, 2024: 10:45 AM

报告人：Hui Wang

摘要号：1044

英文标题：A Multicenter Randomized Controlled Trial of Low-Dose Ruxolitinib for Gvhd Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplantation

时间：Monday, December 9, 2024: 5:45 PM

报告人：Hengwei Wu

摘要号：38

英文标题：The TFG-ROS1 Fusion Is an Oncogenic Driver of Human Myeloid Leukemia

时间：Saturday, December 7, 2024: 9:45 AM

报告人：Jie Sun

摘要号：893

英文标题：Venetoclax Plus Dexamethasone As First-Line Treatment for t(11; 14) Light-Chain Amyloidosis: Preliminary Result of a Phase II Prospective, Multicenter, Single-Arm Study

时间：Monday, December 9, 2024: 3:45 PM

报告人：Kaini Shen

摘要号：222

英文标题：Prospective Study of Avapritinib in Patients with Relapsed/Refractory or MRD-Positive Core-Binding Factor Acute Myeloid Leukemia with KIT Mutations

时间：Saturday, December 7, 2024: 3:15 PM

报告人：Xueqing Dou

摘要号：538

英文标题：Polycomb Repressive Complex 2 Regulates Differentiation-Stage-Specific Autophagy Gene Expression and Safeguards Normal Erythropoiesis

时间：Sunday, December 8, 2024: 12:45 PM

报告人：Jiazhuo Li

摘要号：539

英文标题：A Novel Role of LKB1 in Erythroblast Enucleation

时间：Sunday, December 8, 2024: 1:00 PM

报告人：Yuanlin Xu

摘要号：345

英文标题：Mitochondrial Transcriptional-Translational Conflict Contributes to Defective Erythropoiesis and Disease Progression in Splicing Factor Mutant Myelodysplastic Syndromes

时间：Saturday, December 7, 2024: 4:30 PM

报告人：Qiaoli Li

摘要号：843

英文标题：The Mutated of KRAS gene Determine the Fate of KMT2A-Rearranged AML Patients

时间：Monday, December 9, 2024: 3:15 PM

报告人：Yibo Wu

摘要号：425

英文标题：β2-Adrenergic Receptor Agonist Terbutaline Regulates Macrophage Polarization Via HMGB1 in Immune Thrombocytopenia

时间：Sunday, December 8, 2024: 10:30 AM

报告人：Qiuyu Guo

摘要号：426

英文标题：Differentiation Route Generates Functional Biased Platelets and Responses Distinctly to Varying Physiological Demands

时间：Sunday, December 8, 2024: 10:45 AM

报告人：Jingkun Liu

摘要号：266

英文标题：Elevated Dosing of Recombinant Human Thrombopoietin Accelerates Platelet Engraftment in Allogeneic Hematopoietic Stem Cell Transplantation: A Prospective, Dosage-Optimization, Controlled Clinical Study

时间：Saturday, December 7, 2024: 2:15 PM

报告人：Dan Feng

摘要号：268

英文标题：Epstein-Barr Virus Reactivation and Post-Transplant Lymphoproliferative Disorders after Allo-HSCT in the Era of Letermovir for Cytomegalovirus Prophylaxis

时间：Saturday, December 7, 2024: 2:45 PM

报告人：Jingtao Huang

摘要号：270

英文标题：Safety and Efficacy of VA Combined with Modified BuCy Conditioning Regimen Followed By Allo-HSCT for High-Risk or Refractory/Relapsed Acute Lymphoblastic Leukemia : A Prospective, Single-Center, Single-Arm Clinical Trial

时间：Saturday, December 7, 2024: 3:15 PM

报告人：Xiaoqian Chen

摘要号：164

英文标题：Reconstruction of Megaloblastic Anemia in a Novel Erythroblastic Island Humanized Mouse Model with Mature Circulating Human Red Blood Cells

时间：Saturday, December 7, 2024: 2:15 PM

报告人：Shuang Liu

摘要号：690

英文标题：Parvovirus B19 Originates from Infected Hematopoietic Stem Cells Following Hematopoietic Stem Cell Transplantation

时间：Sunday, December 8, 2024: 5:45 PM

报告人：Xuying Pei

摘要号：971

英文标题：Venetoclax and Decitabine Compared with Standard Intensive Chemotherapy As Induction Therapy in Newly Diagnosed Acute Myeloid Leukemia: Updated Results of a Multicenter, Randomized, Phase 2b Trial

时间：Monday, December 9, 2024: 5:30 PM

报告人：Jing Lu

摘要号：972

英文标题：High-Dose Cytarabine with Idarubicin Versus High-Dose Cytarabine within First Consolidation for Acute Myeloid Leukemia in First Complete Remission: An Open-Label, Multicenter, Randomized, Phase 3 Trial

时间：Monday, December 9, 2024: 5:45 PM

报告人：Zinan Feng

摘要号：576

英文标题：Clinical Implications of CSF-Ctdna Positivity in Newly Diagnosed Diffuse Large B Cell Lymphoma in a Large Cohort

时间：Sunday, December 8, 2024: 1:15 PM

报告人：Jinhua Liang

摘要号：562

英文标题：Procr+ Endothelial Progenitor Cells Modulate Adult Hematopoiesis and Microenvironment Homeostasis Via Notch Signaling

时间：Sunday, December 8, 2024: 12:45 PM

报告人：Chang Xu

摘要号：420

英文标题：A Single-Cell Transcriptomic Atlas of Cytokine Storm in CAR-T Therapy, COVID-19, and SLE

时间：Sunday, December 8, 2024: 10:45 AM

报告人：Xia Li

摘要号：30

英文标题：Clec16a-Mediated Mitophagy Modulates Zebrafish Definitive Hematopoiesis

时间：Saturday, December 7, 2024: 10:45 AM

报告人：Shuyang Cai

摘要号：150

英文标题：Efficient Generation of CAR-T By the First Coacervate-Based Gene Delivery

时间：Saturday, December 7, 2024: 1:15 PM

报告人：Peipei Zhu

摘要号：263

英文标题：Targeting the Hypoxic Microenvironment in Cutaneous Chronic Graft-Versus-Host Disease through PI3Kδ Inhibition

时间：Saturday, December 7, 2024: 3:00 PM

报告人：Yuxi Xu

摘要号：977

英文标题：Faecalibacterium Prausnitzii Confers a Protective Effect Against the Development of NKTCL

时间：Monday, December 9, 2024: 5:30 PM

报告人：Zhuangzhuang Shi

摘要号：452

英文标题：Spatial Architecture of Immune Microenvironment Orchestrating Anti-Lymphoma Immunity and the Response to Immunochemotherapy in EBV+ Diffused Large B Cell Lymphoma Revealed By Imaging Mass Cytometry and Spatial Transcriptome

时间：Sunday, December 8, 2024: 9:45 AM

报告人：Zhijuan Lin

摘要号：156

英文标题：Potent in Vitro and In Vivo Efficacy of Hdz-C123A, a GSPT1 Degrader-Antibody Conjugate Targeting CD123 in Acute Myeloid Leukemia

时间：Saturday, December 7, 2024: 1:15 PM

报告人：Yu Guo

摘要号：599

英文标题：Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Improved Prognosis for Advanced NK/T Cell Lymphoma

时间：Sunday, December 8, 2024: 1:00 PM

报告人：Zhihui Li

摘要号：874

英文标题：CD38 Overexpressed Monocytes Play a Critical Role in the Fibrogenesis in Myeloproliferative Neoplasms and Can be Used As a Therapeutic Target to Ameliorate Fibrosis

时间：Monday, December 9, 2024: 3:30 PM

报告人：Bing Li

摘要号：12

英文标题：Rbm38 Regulates Heme Biosynthesis Via Fine-Tuning the RNA Alternative Splicing, Stability and Translation of Porphyrin Metabolic Enzyme Gene Ferrochelatase (Fech)

时间：Saturday, December 7, 2024: 10:45 AM

报告人：Yang Mei

摘要号：192

英文标题：Exploring the Mechanism of Chromatin Spatial Structure Changes and Transcriptional Regulation in Age-Related Clonal Hematopoiesis Caused By DNMT3A Mutations Using Chromatin Capture Technology

时间：Saturday, December 7, 2024: 3:15 PM

报告人：Yujun Dai

摘要号：964

英文标题：CD7 CAR T-Cell Therapy in Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia: A Retrospective Study

时间：Monday, December 9, 2024: 5:15 PM

报告人：Jing PAN

摘要号：696

英文标题：Haploidentical Peripheral Blood Stem Cell Combined with Bone Marrow or Unrelated Cord Blood As Grafts for Acute Leukemia/Myelodysplastic Syndrome: An Open-Label, Multicenter, Randomized, Phase 3 Trial

时间：Sunday, December 8, 2024: 5:45 PM

报告人：Sijian Yu

摘要号：125

英文标题：Imbalanced Expression of TACI Isoforms Regulated By TNFRSF13B Variants Promotes the Progression of Epstein-Barr Virus-Associated Lymphoproliferative Diseases

时间：Saturday, December 7, 2024: 1:00 PM

报告人：Xinyue Deng

摘要号：328

英文标题：Integrative Multi-Omics Analyses Identify a High-Risk Subgroup of Patients with Poor Prognosis in t(8;21) Acute Myeloid Leukemia

时间：Saturday, December 7, 2024: 4:45 PM

报告人：Yu Liu

摘要号：312

英文标题：Efficacy and Safety of Adding Blinatumomab to First-Line Treatment for Chinese Children with B-Cell Acute Lymphoblastic Leukemia

时间：Saturday, December 7, 2024: 5:15 PM

报告人：Ruidong Zhang

摘要号：904

英文标题：CD33 Antibody-Modified Nanoparticles Encapsulated IL-15 Induce ISG15 to Promote MHC I Expression in Leukemia Cells Via Innate Immunity Pathway Inducing Graft-Versus-Leukemia without Aggravating Graft-Versus-Host Disease

时间：Monday, December 9, 2024: 3:30 PM

报告人：Ruowen Wei

摘要号：372

英文标题：Modified Dual CLL1-CD15 and CLL1-CD16 Icar-T Cells for Mitigating Granulocytopenia Toxicities in the Treatment of Acute Myeloid Leukemia

时间：Saturday, December 7, 2024: 5:15 PM

报告人：Rui Zhang

摘要号：743

英文标题：Single-Cell RNA Analysis of Bone Marrow Mononuclear Cells Reveals Abnormal Activation of T Cells and Monocytes, and Identifies CD35 As a Novel Biomarker and Therapeutic Target in Waldenstrom Macroglobulinemia

时间：Monday, December 9, 2024: 11:30 AM

报告人：Hao Sun

摘要号：300

英文标题：Effects of Low-Molecular-Weight Heparin on Pregnancy Outcomes in Protein S Deficiency: A Prospective, Randomized Controlled Phase II Clinical

时间：Saturday, December 7, 2024: 5:15 PM

报告人：Mengtong Zang

摘要号：54

英文标题：Targeting PRMT9 Overcomes Venetoclax Resistance in AML By Modulating Splicing and Inhibiting Translation

时间：Saturday, December 7, 2024: 10:45 AM

报告人：Yang Li

摘要号：498

英文标题：A Phase I Study of a Novel BCMA×CD3 Bispecific Antibody Emb-06 in Relapsed or Refractory Multiple Myeloma

时间：Sunday, December 8, 2024: 10:45 AM

报告人：Peter T. Tan